The European Medicines Agency has published the first overview listing the recommendations stemming from the assessment of safety signals by the Pharmacovigilance Risk Assessment Committee (PRAC).
Related information:
» EMA News
Details
- Publication date
- 8 October 2013
- Author
- European Medicines Agency